tx a303 781a rabbit Search Results


anti brd9  (Bethyl)
94
Bethyl anti brd9
Anti Brd9, supplied by Bethyl, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tx+a303+781a+rabbit/pmc10930984-119-39-40?v=Bethyl
Average 94 stars, based on 1 article reviews
anti brd9 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
004-650  (Bio-Techne corporation)
96
Bio-Techne corporation 004-650
004 650, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tx+a303+781a+rabbit/bio-techne+corporation___004-650?v=Bio-Techne+corporation
Average 96 stars, based on 1 article reviews
004-650 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier
simple-western-system-0  (Bio-Techne corporation)
99
Bio-Techne corporation simple-western-system-0
Simple Western System 0, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tx+a303+781a+rabbit/bio-techne+corporation___simple-western-system?v=Bio-Techne+corporation
Average 99 stars, based on 1 article reviews
simple-western-system-0 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
rabbit anti human brd9 polyclonal antibody  (Proteintech)
93
Proteintech rabbit anti human brd9 polyclonal antibody
Identification of proteins interacting with PXR. ShP51 cells were treated with rifampicin for 24 hr. Co-immunoprecipitation with anti-PXR antibody was performed using whole cell lysates followed by mass spectrometric analysis. (A) The numbers of proteins detected in the immunoprecipitant of rifampicin-and/or non-treated cells are shown in a Venn diagram. The ratios of the protein amounts of the rifampicin-treated sample to those of non-treated sample are shown in the bottom graph. (B) The proteins whose abundance ratio rifampicin-treated/non-treated was > 2.0 (168 proteins) as well as proteins detected only in rifampicin-treated sample (804 proteins) were subjected to pathway analysis using DAVID Bioinformatics Resources ( https://david.ncifcrf.gov/home.jsp ). (C) Schematic representation of BAF, PBAF, and ncBAF composition reported by ref. 21 and ref. 58. (D) Glycerol gradient sedimentation was performed using ShP51 cell nuclear extracts, and ARID1A, BRD7, <t>BRD9,</t> and PXR proteins were detected by Western blotting. Source data are available online for this figure.
Rabbit Anti Human Brd9 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tx+a303+781a+rabbit/bio_rxiv__2023__02__03__527063-213-0-27?v=Proteintech
Average 93 stars, based on 1 article reviews
rabbit anti human brd9 polyclonal antibody - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
hrp-conjugated anti-mouse, promega  (Promega)
90
Promega hrp-conjugated anti-mouse, promega
Identification of proteins interacting with PXR. ShP51 cells were treated with rifampicin for 24 hr. Co-immunoprecipitation with anti-PXR antibody was performed using whole cell lysates followed by mass spectrometric analysis. (A) The numbers of proteins detected in the immunoprecipitant of rifampicin-and/or non-treated cells are shown in a Venn diagram. The ratios of the protein amounts of the rifampicin-treated sample to those of non-treated sample are shown in the bottom graph. (B) The proteins whose abundance ratio rifampicin-treated/non-treated was > 2.0 (168 proteins) as well as proteins detected only in rifampicin-treated sample (804 proteins) were subjected to pathway analysis using DAVID Bioinformatics Resources ( https://david.ncifcrf.gov/home.jsp ). (C) Schematic representation of BAF, PBAF, and ncBAF composition reported by ref. 21 and ref. 58. (D) Glycerol gradient sedimentation was performed using ShP51 cell nuclear extracts, and ARID1A, BRD7, <t>BRD9,</t> and PXR proteins were detected by Western blotting. Source data are available online for this figure.
Hrp Conjugated Anti Mouse, Promega, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tx+a303+781a+rabbit/10__1158_slash_1078___0432__ccr___21___3603-67-133-138?v=Promega
Average 90 stars, based on 1 article reviews
hrp-conjugated anti-mouse, promega - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
rabbit anti-ssx1 polyclonal  (MyBiosource Biotechnology)
90
MyBiosource Biotechnology rabbit anti-ssx1 polyclonal
Identification of proteins interacting with PXR. ShP51 cells were treated with rifampicin for 24 hr. Co-immunoprecipitation with anti-PXR antibody was performed using whole cell lysates followed by mass spectrometric analysis. (A) The numbers of proteins detected in the immunoprecipitant of rifampicin-and/or non-treated cells are shown in a Venn diagram. The ratios of the protein amounts of the rifampicin-treated sample to those of non-treated sample are shown in the bottom graph. (B) The proteins whose abundance ratio rifampicin-treated/non-treated was > 2.0 (168 proteins) as well as proteins detected only in rifampicin-treated sample (804 proteins) were subjected to pathway analysis using DAVID Bioinformatics Resources ( https://david.ncifcrf.gov/home.jsp ). (C) Schematic representation of BAF, PBAF, and ncBAF composition reported by ref. 21 and ref. 58. (D) Glycerol gradient sedimentation was performed using ShP51 cell nuclear extracts, and ARID1A, BRD7, <t>BRD9,</t> and PXR proteins were detected by Western blotting. Source data are available online for this figure.
Rabbit Anti Ssx1 Polyclonal, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tx+a303+781a+rabbit/pmc06277197-321-26-29?v=MyBiosource+Biotechnology
Average 90 stars, based on 1 article reviews
rabbit anti-ssx1 polyclonal - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
polyclonal mybiosource mbs9127222 antibody  (MyBiosource Biotechnology)
90
MyBiosource Biotechnology polyclonal mybiosource mbs9127222 antibody
Identification of proteins interacting with PXR. ShP51 cells were treated with rifampicin for 24 hr. Co-immunoprecipitation with anti-PXR antibody was performed using whole cell lysates followed by mass spectrometric analysis. (A) The numbers of proteins detected in the immunoprecipitant of rifampicin-and/or non-treated cells are shown in a Venn diagram. The ratios of the protein amounts of the rifampicin-treated sample to those of non-treated sample are shown in the bottom graph. (B) The proteins whose abundance ratio rifampicin-treated/non-treated was > 2.0 (168 proteins) as well as proteins detected only in rifampicin-treated sample (804 proteins) were subjected to pathway analysis using DAVID Bioinformatics Resources ( https://david.ncifcrf.gov/home.jsp ). (C) Schematic representation of BAF, PBAF, and ncBAF composition reported by ref. 21 and ref. 58. (D) Glycerol gradient sedimentation was performed using ShP51 cell nuclear extracts, and ARID1A, BRD7, <t>BRD9,</t> and PXR proteins were detected by Western blotting. Source data are available online for this figure.
Polyclonal Mybiosource Mbs9127222 Antibody, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tx+a303+781a+rabbit/10__7554_slash_elife__41305-359-37-40?v=MyBiosource+Biotechnology
Average 90 stars, based on 1 article reviews
polyclonal mybiosource mbs9127222 antibody - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
polyclonal mybiosource mbs9408371 antibody  (MyBiosource Biotechnology)
90
MyBiosource Biotechnology polyclonal mybiosource mbs9408371 antibody
Identification of proteins interacting with PXR. ShP51 cells were treated with rifampicin for 24 hr. Co-immunoprecipitation with anti-PXR antibody was performed using whole cell lysates followed by mass spectrometric analysis. (A) The numbers of proteins detected in the immunoprecipitant of rifampicin-and/or non-treated cells are shown in a Venn diagram. The ratios of the protein amounts of the rifampicin-treated sample to those of non-treated sample are shown in the bottom graph. (B) The proteins whose abundance ratio rifampicin-treated/non-treated was > 2.0 (168 proteins) as well as proteins detected only in rifampicin-treated sample (804 proteins) were subjected to pathway analysis using DAVID Bioinformatics Resources ( https://david.ncifcrf.gov/home.jsp ). (C) Schematic representation of BAF, PBAF, and ncBAF composition reported by ref. 21 and ref. 58. (D) Glycerol gradient sedimentation was performed using ShP51 cell nuclear extracts, and ARID1A, BRD7, <t>BRD9,</t> and PXR proteins were detected by Western blotting. Source data are available online for this figure.
Polyclonal Mybiosource Mbs9408371 Antibody, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tx+a303+781a+rabbit/10__7554_slash_elife__41305-359-30-33?v=MyBiosource+Biotechnology
Average 90 stars, based on 1 article reviews
polyclonal mybiosource mbs9408371 antibody - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
blot anti brd7  (Bethyl)
92
Bethyl blot anti brd7
Identification of proteins interacting with PXR. ShP51 cells were treated with rifampicin for 24 hr. Co-immunoprecipitation with anti-PXR antibody was performed using whole cell lysates followed by mass spectrometric analysis. (A) The numbers of proteins detected in the immunoprecipitant of rifampicin-and/or non-treated cells are shown in a Venn diagram. The ratios of the protein amounts of the rifampicin-treated sample to those of non-treated sample are shown in the bottom graph. (B) The proteins whose abundance ratio rifampicin-treated/non-treated was > 2.0 (168 proteins) as well as proteins detected only in rifampicin-treated sample (804 proteins) were subjected to pathway analysis using DAVID Bioinformatics Resources ( https://david.ncifcrf.gov/home.jsp ). (C) Schematic representation of BAF, PBAF, and ncBAF composition reported by ref. 21 and ref. 58. (D) Glycerol gradient sedimentation was performed using ShP51 cell nuclear extracts, and ARID1A, BRD7, <t>BRD9,</t> and PXR proteins were detected by Western blotting. Source data are available online for this figure.
Blot Anti Brd7, supplied by Bethyl, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tx+a303+781a+rabbit/pm35839307-98-4-6?v=Bethyl
Average 92 stars, based on 1 article reviews
blot anti brd7 - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier
anti brg1  (Santa Cruz Biotechnology)
94
Santa Cruz Biotechnology anti brg1
Identification of proteins interacting with PXR. ShP51 cells were treated with rifampicin for 24 hr. Co-immunoprecipitation with anti-PXR antibody was performed using whole cell lysates followed by mass spectrometric analysis. (A) The numbers of proteins detected in the immunoprecipitant of rifampicin-and/or non-treated cells are shown in a Venn diagram. The ratios of the protein amounts of the rifampicin-treated sample to those of non-treated sample are shown in the bottom graph. (B) The proteins whose abundance ratio rifampicin-treated/non-treated was > 2.0 (168 proteins) as well as proteins detected only in rifampicin-treated sample (804 proteins) were subjected to pathway analysis using DAVID Bioinformatics Resources ( https://david.ncifcrf.gov/home.jsp ). (C) Schematic representation of BAF, PBAF, and ncBAF composition reported by ref. 21 and ref. 58. (D) Glycerol gradient sedimentation was performed using ShP51 cell nuclear extracts, and ARID1A, BRD7, <t>BRD9,</t> and PXR proteins were detected by Western blotting. Source data are available online for this figure.
Anti Brg1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tx+a303+781a+rabbit/pmc04990482-359-0-1?v=Santa+Cruz+Biotechnology
Average 94 stars, based on 1 article reviews
anti brg1 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
goat polyclonal anti brg1  (Bethyl)
93
Bethyl goat polyclonal anti brg1
KEY RESOURCES TABLE
Goat Polyclonal Anti Brg1, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tx+a303+781a+rabbit/pmc08312579-357-60-64?v=Bethyl
Average 93 stars, based on 1 article reviews
goat polyclonal anti brg1 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
rabbit anti crbn polyclonal  (Proteintech)
93
Proteintech rabbit anti crbn polyclonal

Rabbit Anti Crbn Polyclonal, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tx+a303+781a+rabbit/pmc06277197-319-26-29?v=Proteintech
Average 93 stars, based on 1 article reviews
rabbit anti crbn polyclonal - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

Image Search Results


Identification of proteins interacting with PXR. ShP51 cells were treated with rifampicin for 24 hr. Co-immunoprecipitation with anti-PXR antibody was performed using whole cell lysates followed by mass spectrometric analysis. (A) The numbers of proteins detected in the immunoprecipitant of rifampicin-and/or non-treated cells are shown in a Venn diagram. The ratios of the protein amounts of the rifampicin-treated sample to those of non-treated sample are shown in the bottom graph. (B) The proteins whose abundance ratio rifampicin-treated/non-treated was > 2.0 (168 proteins) as well as proteins detected only in rifampicin-treated sample (804 proteins) were subjected to pathway analysis using DAVID Bioinformatics Resources ( https://david.ncifcrf.gov/home.jsp ). (C) Schematic representation of BAF, PBAF, and ncBAF composition reported by ref. 21 and ref. 58. (D) Glycerol gradient sedimentation was performed using ShP51 cell nuclear extracts, and ARID1A, BRD7, BRD9, and PXR proteins were detected by Western blotting. Source data are available online for this figure.

Journal: bioRxiv

Article Title: ncBAF, a chromatin remodeler, enhances PXR-mediated transcriptional activation in the human and mouse liver

doi: 10.1101/2023.02.03.527063

Figure Lengend Snippet: Identification of proteins interacting with PXR. ShP51 cells were treated with rifampicin for 24 hr. Co-immunoprecipitation with anti-PXR antibody was performed using whole cell lysates followed by mass spectrometric analysis. (A) The numbers of proteins detected in the immunoprecipitant of rifampicin-and/or non-treated cells are shown in a Venn diagram. The ratios of the protein amounts of the rifampicin-treated sample to those of non-treated sample are shown in the bottom graph. (B) The proteins whose abundance ratio rifampicin-treated/non-treated was > 2.0 (168 proteins) as well as proteins detected only in rifampicin-treated sample (804 proteins) were subjected to pathway analysis using DAVID Bioinformatics Resources ( https://david.ncifcrf.gov/home.jsp ). (C) Schematic representation of BAF, PBAF, and ncBAF composition reported by ref. 21 and ref. 58. (D) Glycerol gradient sedimentation was performed using ShP51 cell nuclear extracts, and ARID1A, BRD7, BRD9, and PXR proteins were detected by Western blotting. Source data are available online for this figure.

Article Snippet: Rabbit anti-human BRD9 polyclonal antibody (A303-781A), rabbit anti-ARID1A (GTX129433) antibody, and rabbit anti-SMARCD1 (BAF60A) antibody (10998-2-AP) were obtained from Bethyl Laboratories (Montgomery, AL), Genetex (Irvine, CA), and Proteintech (Rosemont, IL), respectively.

Techniques: Immunoprecipitation, Sedimentation, Western Blot

Interaction between PXR and BRD9. HEK293T cells were transfected with FLAG-PXR along with BRD7-His or BRD9-His plasmid (A), transfected with BRD9-His along with FLAG-PXR or FLAG-PXR K109A plasmid (B), or transfected with FLAG-PXR and BRD9-His plasmids followed by treatment with rifampicin along with iBRD9 for 1 hr (C). ShP51 cells were treated with rifampicin along with iBRD9 for 24 hr (D). (A, B, and C) Immunoprecipitation with anti-FLAG antibody was performed using whole HEK293T cell lysates, and FLAG and His tags were detected by Western blotting. (D) Immunoprecipitation with anti-PXR antibody was performed using ShP51 cell nuclear extracts, and BRD9 and PXR proteins were detected by Western blotting. IP: immunoprecipitation, WB: Western blotting. The experiments were repeated two times with similar results.

Journal: bioRxiv

Article Title: ncBAF, a chromatin remodeler, enhances PXR-mediated transcriptional activation in the human and mouse liver

doi: 10.1101/2023.02.03.527063

Figure Lengend Snippet: Interaction between PXR and BRD9. HEK293T cells were transfected with FLAG-PXR along with BRD7-His or BRD9-His plasmid (A), transfected with BRD9-His along with FLAG-PXR or FLAG-PXR K109A plasmid (B), or transfected with FLAG-PXR and BRD9-His plasmids followed by treatment with rifampicin along with iBRD9 for 1 hr (C). ShP51 cells were treated with rifampicin along with iBRD9 for 24 hr (D). (A, B, and C) Immunoprecipitation with anti-FLAG antibody was performed using whole HEK293T cell lysates, and FLAG and His tags were detected by Western blotting. (D) Immunoprecipitation with anti-PXR antibody was performed using ShP51 cell nuclear extracts, and BRD9 and PXR proteins were detected by Western blotting. IP: immunoprecipitation, WB: Western blotting. The experiments were repeated two times with similar results.

Article Snippet: Rabbit anti-human BRD9 polyclonal antibody (A303-781A), rabbit anti-ARID1A (GTX129433) antibody, and rabbit anti-SMARCD1 (BAF60A) antibody (10998-2-AP) were obtained from Bethyl Laboratories (Montgomery, AL), Genetex (Irvine, CA), and Proteintech (Rosemont, IL), respectively.

Techniques: Transfection, Plasmid Preparation, Immunoprecipitation, Western Blot

Effects of BRD7 or BRD9 knockdown or BRD9 inhibition on PXR-mediated induction of CYP3A4 expression. (A) ShP51 cells were transfected with siRNA for BRD7 (siBRD7) or BRD9 (siBRD9). After incubation for 24 hr, the cells were treated with 10 μM rifampicin or 10 μM simvastatin. ShP51 cells (B), HepaRG cells (C), and human primary hepatocytes (D and E) were treated with rifampicin or simvastatin along with iBRD9. PXR, RXRα and GAPDH (A and B) protein, CYP3A4 and GAPDH mRNA (A-D), and CYP3A4 enzyme activity (E) were evaluated by Western blotting, real-time RT□PCR, and P450-Glo assay. Each column represents the mean ± SD (n =3-4). n refers to biological repeats. * P < 0.05, ** P < 0.01, and *** P < 0.001, compared with NT, † P < 0.05, †† P < 0.01, and ††† P < 0.001, compared with siControl or iBRD9 (−). NT: non-treatment. The experiments were repeated two times with similar results.

Journal: bioRxiv

Article Title: ncBAF, a chromatin remodeler, enhances PXR-mediated transcriptional activation in the human and mouse liver

doi: 10.1101/2023.02.03.527063

Figure Lengend Snippet: Effects of BRD7 or BRD9 knockdown or BRD9 inhibition on PXR-mediated induction of CYP3A4 expression. (A) ShP51 cells were transfected with siRNA for BRD7 (siBRD7) or BRD9 (siBRD9). After incubation for 24 hr, the cells were treated with 10 μM rifampicin or 10 μM simvastatin. ShP51 cells (B), HepaRG cells (C), and human primary hepatocytes (D and E) were treated with rifampicin or simvastatin along with iBRD9. PXR, RXRα and GAPDH (A and B) protein, CYP3A4 and GAPDH mRNA (A-D), and CYP3A4 enzyme activity (E) were evaluated by Western blotting, real-time RT□PCR, and P450-Glo assay. Each column represents the mean ± SD (n =3-4). n refers to biological repeats. * P < 0.05, ** P < 0.01, and *** P < 0.001, compared with NT, † P < 0.05, †† P < 0.01, and ††† P < 0.001, compared with siControl or iBRD9 (−). NT: non-treatment. The experiments were repeated two times with similar results.

Article Snippet: Rabbit anti-human BRD9 polyclonal antibody (A303-781A), rabbit anti-ARID1A (GTX129433) antibody, and rabbit anti-SMARCD1 (BAF60A) antibody (10998-2-AP) were obtained from Bethyl Laboratories (Montgomery, AL), Genetex (Irvine, CA), and Proteintech (Rosemont, IL), respectively.

Techniques: Knockdown, Inhibition, Expressing, Transfection, Incubation, Activity Assay, Western Blot, Glo Assay

Effects of iBRD9 on PXR binding to chromatin and changes in chromatin structure. (A) ShP51 cells were treated with 20 μM rifampicin along with 20 μM iBRD9 for 24 hr. SSE analysis followed by Western blotting for BRD9 or PXR was performed. The peaks of band intensity are shown in red. (B) Schematic representation of the upstream of CYP3A4 gene. ShP51 cells were treated with 10 μM rifampicin along with 10 μM iBRD9 for 24 hr. Immunoprecipitation with anti-PXR antibody (C) or anti-BRD9 antibody (D) was performed using chromatin from ShP51 cells. Enrichment of the proximal promoter, distal enhancer, and far enhancer of CYP3A4 was evaluated by real-time PCR. (E) Changes in chromatin structure was evaluated by FAIRE followed by real-time PCR. Each column represents the mean ± SD (n = 3). n refers to biological repeats. * P < 0.05, ** P < 0.01, and *** P < 0.001, compared with NT, †† P < 0.01 and ††† P < 0.001, compared with iBRD9 (−). NT: non-treatment. The experiments were repeated two times with similar results.

Journal: bioRxiv

Article Title: ncBAF, a chromatin remodeler, enhances PXR-mediated transcriptional activation in the human and mouse liver

doi: 10.1101/2023.02.03.527063

Figure Lengend Snippet: Effects of iBRD9 on PXR binding to chromatin and changes in chromatin structure. (A) ShP51 cells were treated with 20 μM rifampicin along with 20 μM iBRD9 for 24 hr. SSE analysis followed by Western blotting for BRD9 or PXR was performed. The peaks of band intensity are shown in red. (B) Schematic representation of the upstream of CYP3A4 gene. ShP51 cells were treated with 10 μM rifampicin along with 10 μM iBRD9 for 24 hr. Immunoprecipitation with anti-PXR antibody (C) or anti-BRD9 antibody (D) was performed using chromatin from ShP51 cells. Enrichment of the proximal promoter, distal enhancer, and far enhancer of CYP3A4 was evaluated by real-time PCR. (E) Changes in chromatin structure was evaluated by FAIRE followed by real-time PCR. Each column represents the mean ± SD (n = 3). n refers to biological repeats. * P < 0.05, ** P < 0.01, and *** P < 0.001, compared with NT, †† P < 0.01 and ††† P < 0.001, compared with iBRD9 (−). NT: non-treatment. The experiments were repeated two times with similar results.

Article Snippet: Rabbit anti-human BRD9 polyclonal antibody (A303-781A), rabbit anti-ARID1A (GTX129433) antibody, and rabbit anti-SMARCD1 (BAF60A) antibody (10998-2-AP) were obtained from Bethyl Laboratories (Montgomery, AL), Genetex (Irvine, CA), and Proteintech (Rosemont, IL), respectively.

Techniques: Binding Assay, Western Blot, Immunoprecipitation, Real-time Polymerase Chain Reaction

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: NELL2-cdc42 signaling regulates BAF complexes and Ewing sarcoma cell growth

doi: 10.1016/j.celrep.2021.109254

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: The following antibodies were used: rabbit polyclonal anti-FLI1 (ab15289, Abcam); mouse monoclonal anti-FLAG M2 (F1804, MilliporeSigma); rabbit monoclonal anti-NELL2 (ab181376, Abcam); goat polyclonal anti-PGK1 (sc-17943, Santa Cruz Biotechnology); rabbit polyclonal anti-Robo3 (LS-C345713, LSBio); goat polyclonal anti-Robo3 (PA5-18714, Thermo Fisher Scientific); mouse monoclonal anti-cdc42 (ACD03, Cytoskeleton); rabbit polyclonal anti-Rac1/2/3 (2465, Cell Signaling Technologies); rabbit polyclonal anti-Rho A (2117, Cell Signaling Technologies); goat polyclonal anti-BRG1 (A303-877A, Bethyl Laboratories); rabbit monoclonal anti-BRG1 (49360, Cell Signaling Technologies); rabbit polyclonal anti-BRM (A301-014A-T, Bethyl Laboratories); mouse monoclonal anti-ARID1A/BAF250 (sc-32761, Santa Cruz Biotechnology); rabbit polyclonal anti-BAF170 (A301-039A-T, Bethyl Laboratories); rabbit monoclonal anti-BAF155 (11956, Cell Signaling Technologies); rabbit polyclonal anti-BAF60B (A301-596A-T, Bethyl Laboratories); rabbit polyclonal anti-BAF57 (A300-810A-T, Bethyl Laboratories); rabbit polyclonal anti-BAF53A (A301-391A-T, Bethyl Laboratories); rabbit monoclonal anti-BAF47 (8745, Cell Signaling Technologies); rabbit polyclonal anti-BRD9 (A303-781A-T, Bethyl Laboratories); rabbit monoclonal anti-SS18 (21792, Cell Signaling Technologies); rabbit monoclonal anti-CD133 (64326, Cell Signaling Technologies); rabbit polyclonal anti-srGAP1 (A301-286A-T, Bethyl Laboratories); rabbit polyclonal anti-srGAP2 (GTX130797, GeneTex); mouse monoclonal anti-tubulin (DM1A, Thermo Fisher Scientific); rabbit polyclonal anti-β-actin (4967, Cell Signaling Technologies); mouse monoclonal anti-Rpb1 (2629, Cell Signaling Technologies); rabbit monoclonal anti-cdc6 (3387, Cell Signaling Technologies); rabbit monoclonal anti-caveolin-1 (3267, Cell Signaling Technologies); rabbit polyclonal anti-phospho-caveolin-1 (3251, Cell Signaling Technologies); rabbit monoclonal anti-Src (2123, Cell Signaling Technologies); rabbit monoclonal anti-phospho-Src Family (6943, Cell Signaling Technologies); and rabbit polyclonal anti-GDF6 (NBP1-91934, Novus Biologicals).

Techniques: Control, Virus, Recombinant, Transfection, Enzyme-linked Immunosorbent Assay, Mass Spectrometry, Plasmid Preparation

Journal: eLife

Article Title: Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma

doi: 10.7554/eLife.41305

Figure Lengend Snippet:

Article Snippet: rabbit anti-BRD9 polyclonal, Bethyl Labs (catalogue number: A303-781A), rabbit anti-HA monoclonal, Cell Signaling Technology (catalogue number: 3724S), mouse anti-ACTIN monoclonal, Cell Signaling Technology (catalogue number: 3700S), rabbit anti-CRBN polyclonal, Proteintech (catalogue number: 11435–1-AP), rabbit anti-V5 polyclonal, Bethyl Labs (catalogue number: A190-220A).

Techniques: Western Blot, Recombinant, Mutagenesis, Software